Clinical Approach to Oliguria
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of oliguria
Oliguria is one of the most critical clinical signs encountered in hospitalized patients, serving as an early warning indicator of kidney dysfunction or inadequate perfusion. Acute kidney injury (AKI), of which oliguria is a cardinal manifestation, affects approximately 10-15% of all hospitalized patients and up to 50-60% of patients in intensive care units. The presence of oliguria is independently associated with increased mortality, with studies demonstrating that even brief periods of reduced urine output correlate with worse patient outcomes. Early recognition and appropriate management of oliguria can prevent progression to established acute kidney injury and reduce the need for renal replacement therapy.
Definition
Oliguria is defined as urine output less than 400-500 mL per 24 hours in adults, or less than 0.5 mL/kg/hour for at least 6 hours. Anuria represents the extreme end of the spectrum, defined as urine output less than 50-100 mL per 24 hours. Normal adult urine output ranges from 800-2000 mL per day, depending on fluid intake, and reflects the kidney’s ability to regulate fluid balance, excrete waste products, and maintain electrolyte homeostasis.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Hours to days | Hypovolemia, sepsis, nephrotoxins, obstruction, acute glomerulonephritis | Potentially reversible if identified and treated early; high urgency for evaluation |
| Subacute | Days to weeks | Acute interstitial nephritis, progressive glomerulonephritis, bilateral ureteric obstruction | May indicate evolving intrinsic renal disease; requires systematic workup |
| Chronic | Weeks to months | Advanced chronic kidney disease, end-stage renal disease | Often irreversible; reflects significant nephron loss; may require renal replacement therapy |
Classification by Mechanism: The Three Categories
Prerenal (55-60%)
Mechanism: Reduced renal perfusion with intact tubular function
Key feature: Kidneys respond appropriately by conserving sodium and water
Reversibility: Rapidly reversible with restoration of perfusion
Intrinsic Renal (35-40%)
Mechanism: Structural damage to glomeruli, tubules, interstitium, or vessels
Key feature: Impaired tubular function with inability to concentrate urine
Reversibility: Variable; depends on extent and type of injury
Postrenal (5-10%)
Mechanism: Obstruction of urine flow anywhere from renal pelvis to urethra
Key feature: Must be bilateral (or unilateral in single kidney) to cause oliguria
Reversibility: Often reversible with relief of obstruction
Classification by Clinical Setting
| Setting | Most Common Causes | Key Considerations |
|---|---|---|
| Community-acquired | Dehydration, heart failure, urinary obstruction (benign prostatic hyperplasia, stones), nephrotoxic medications (nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors) | Often prerenal; medication review essential; obstruction more common in elderly males |
| Hospital-acquired | Sepsis, contrast-induced nephropathy, postoperative hypoperfusion, nephrotoxic drugs (aminoglycosides, vancomycin) | Multiple insults common; iatrogenic causes frequent; close monitoring required |
| Intensive care unit | Septic shock, cardiogenic shock, abdominal compartment syndrome, multiorgan dysfunction | Often multifactorial; high mortality; early renal replacement therapy may be needed |
| Postoperative | Hypovolemia, hypotension, nephrotoxic agents, aortic cross-clamping, cardiopulmonary bypass | Volume status often difficult to assess; third-spacing common; timing related to surgery |
Severity Classification: KDIGO Staging for Acute Kidney Injury
| Stage | Serum Creatinine Criteria | Urine Output Criteria | Clinical Implications |
|---|---|---|---|
| Stage 1 | 1.5-1.9 times baseline OR increase ≥0.3 mg/dL | Less than 0.5 mL/kg/hour for 6-12 hours | Early recognition critical; often reversible with intervention |
| Stage 2 | 2.0-2.9 times baseline | Less than 0.5 mL/kg/hour for ≥12 hours | Significant injury; nephrology consultation recommended |
| Stage 3 | 3.0 times baseline OR increase to ≥4.0 mg/dL OR initiation of renal replacement therapy | Less than 0.3 mL/kg/hour for ≥24 hours OR anuria for ≥12 hours | Severe injury; high mortality; prepare for possible dialysis |
Key Concept: The Prerenal-Intrinsic Continuum
Prerenal azotemia and acute tubular necrosis exist on a continuum. Prolonged prerenal states (typically greater than 24-48 hours of significant hypoperfusion) lead to ischemic tubular injury and progression to intrinsic acute kidney injury. This emphasizes the importance of early recognition and treatment of prerenal oliguria before irreversible tubular damage occurs. The window for intervention is often measured in hours, not days.
Clinical Significance by the Numbers
- 10-15% of hospitalized patients develop acute kidney injury
- 50-60% of intensive care unit patients experience acute kidney injury
- 5-6% of intensive care unit patients with acute kidney injury require renal replacement therapy
- 40-50% mortality rate in patients with severe acute kidney injury requiring dialysis
- 20-50% of acute kidney injury survivors develop chronic kidney disease
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of oliguria
Understanding the pathophysiology of urine production is essential for diagnosing and managing oliguria. The kidneys receive approximately 20-25% of cardiac output (about 1000-1200 mL/min), yet produce only 1-2 mL/min of urine under normal conditions. This remarkable efficiency reflects the kidney’s sophisticated mechanisms for regulating glomerular filtration, tubular reabsorption, and concentration. Oliguria results when any component of this system fails—whether from inadequate blood delivery (prerenal), intrinsic kidney damage (intrinsic renal), or obstruction to urine outflow (postrenal).
Normal Urine Production: Key Steps
| Step | Location | Process | Volume Handled |
|---|---|---|---|
| 1. Glomerular Filtration | Glomerulus | Plasma filtered across glomerular capillaries based on hydrostatic and oncotic pressure gradients | ~180 L/day (125 mL/min glomerular filtration rate) |
| 2. Proximal Tubule Reabsorption | Proximal convoluted tubule | Bulk reabsorption of 65-70% of filtered sodium, water, glucose, amino acids, bicarbonate | ~120 L/day reabsorbed |
| 3. Loop of Henle | Descending and ascending limbs | Countercurrent multiplication creates medullary concentration gradient; 25% sodium reabsorption | ~45 L/day reabsorbed |
| 4. Distal Tubule | Distal convoluted tubule | Fine-tuning of sodium, calcium, and potassium; aldosterone-responsive | ~10 L/day reabsorbed |
| 5. Collecting Duct | Cortical and medullary collecting duct | Final concentration of urine; antidiuretic hormone-dependent water reabsorption | ~4 L/day reabsorbed; final urine 1-2 L/day |
Key Regulatory Mechanisms
Renin-Angiotensin-Aldosterone System
Trigger: Decreased renal perfusion pressure, decreased sodium delivery to macula densa
Effect: Angiotensin II causes efferent arteriolar constriction (maintains glomerular filtration rate), systemic vasoconstriction, aldosterone release (sodium retention)
Clinical relevance: Explains why angiotensin-converting enzyme inhibitors and angiotensin receptor blockers can precipitate acute kidney injury in volume-depleted patients
Antidiuretic Hormone
Trigger: Increased plasma osmolality, decreased blood volume, stress, nausea, pain
Effect: Increases water permeability in collecting duct via aquaporin-2 channels; produces concentrated urine
Clinical relevance: Concentrated urine (high specific gravity, high osmolality) suggests intact tubular function and prerenal etiology
Tubuloglomerular Feedback
Trigger: Increased sodium chloride delivery to macula densa
Effect: Afferent arteriolar constriction reduces glomerular filtration rate; prevents excessive sodium loss
Clinical relevance: Autoregulation fails when mean arterial pressure falls below 65-70 mmHg; glomerular filtration rate becomes pressure-dependent
Prerenal Oliguria: Mechanisms of Reduced Perfusion
| Category | Mechanism | Examples | Renal Response |
|---|---|---|---|
| Hypovolemia (True Volume Depletion) | Decreased intravascular volume leads to decreased cardiac output and renal blood flow | Hemorrhage, dehydration, diarrhea, vomiting, burns, third-spacing | Maximal sodium and water retention; urine sodium less than 20 mEq/L; fractional excretion of sodium less than 1% |
| Decreased Effective Circulating Volume | Total body water may be increased, but effective arterial blood volume is reduced | Heart failure, cirrhosis with ascites, nephrotic syndrome, severe hypoalbuminemia | Neurohormonal activation (renin-angiotensin-aldosterone system, antidiuretic hormone, sympathetic nervous system); avid sodium retention |
| Decreased Cardiac Output | Pump failure reduces renal perfusion despite adequate intravascular volume | Cardiogenic shock, severe arrhythmias, massive pulmonary embolism, cardiac tamponade | Similar to hypovolemia; kidneys cannot distinguish low-output states |
| Renal Vasoconstriction | Increased renal vascular resistance reduces glomerular filtration rate despite adequate systemic pressure | Hepatorenal syndrome, nonsteroidal anti-inflammatory drugs, calcineurin inhibitors, contrast agents, hypercalcemia | Afferent arteriolar constriction predominates; reduced glomerular capillary pressure |
| Efferent Arteriolar Dilation | Loss of efferent tone reduces glomerular capillary pressure and filtration | Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers (especially in bilateral renal artery stenosis or volume depletion) | Reduced filtration fraction; unable to maintain glomerular filtration rate when perfusion pressure is borderline |
Intrinsic Renal Oliguria: Mechanisms of Kidney Injury
| Location of Injury | Pathophysiology | Causes | Characteristic Findings |
|---|---|---|---|
| Tubular (Acute Tubular Necrosis) | Ischemia or toxins cause tubular epithelial cell death; cellular debris obstructs tubules; backleak of filtrate through damaged epithelium | Prolonged prerenal states, sepsis, aminoglycosides, contrast media, myoglobin, hemoglobin | Muddy brown granular casts; fractional excretion of sodium greater than 2%; urine sodium greater than 40 mEq/L; isosthenuria |
| Glomerular | Inflammatory damage to glomerular basement membrane and podocytes; reduced filtration surface area; crescents may compress capillaries | Rapidly progressive glomerulonephritis, anti-glomerular basement membrane disease, lupus nephritis, immunoglobulin A nephropathy | Red blood cell casts, dysmorphic red blood cells, proteinuria (often nephritic range); may have systemic features |
| Interstitial | Inflammatory infiltrate in interstitium causes tubular dysfunction; edema compresses tubules and peritubular capillaries | Drug-induced (antibiotics, proton pump inhibitors, nonsteroidal anti-inflammatory drugs), infections, autoimmune diseases | White blood cell casts, eosinophiluria (in allergic causes); fever, rash, eosinophilia in drug-induced cases |
| Vascular | Occlusion or damage to renal arteries, arterioles, or microvasculature reduces glomerular perfusion | Renal artery thrombosis/embolism, cholesterol emboli, thrombotic microangiopathy, malignant hypertension, vasculitis | Variable; may see schistocytes in thrombotic microangiopathy; flank pain in renal infarction; livedo reticularis in cholesterol emboli |
Phases of Acute Tubular Necrosis
- Initiation phase (hours to days): Initial insult occurs; glomerular filtration rate begins to decline; potentially preventable with early intervention
- Extension phase (1-2 days): Ongoing hypoxia and inflammation; cell death continues; inflammatory mediators amplify injury
- Maintenance phase (1-2 weeks): Established injury with persistent oliguria; glomerular filtration rate at nadir; complications (hyperkalemia, acidosis, volume overload) most likely
- Recovery phase (weeks to months): Tubular regeneration; diuretic phase with potential for volume depletion and electrolyte abnormalities; gradual return of concentrating ability
Postrenal Oliguria: Mechanisms of Obstruction
| Level of Obstruction | Mechanism | Common Causes | Key Points |
|---|---|---|---|
| Intrarenal (Tubular) | Intratubular crystals or debris obstruct flow at tubular level | Uric acid crystals (tumor lysis syndrome), acyclovir, methotrexate, sulfonamides, myeloma cast nephropathy | Often classified as intrinsic; prevention with hydration and urine alkalinization when appropriate |
| Ureteral (Bilateral or Unilateral in Solitary Kidney) | Obstruction of urine flow from renal pelvis to bladder; back-pressure transmitted to nephrons | Stones, retroperitoneal fibrosis, malignancy (cervical, prostate, bladder), surgical ligation | Must be bilateral to cause oliguria (unless solitary kidney); hydronephrosis on imaging |
| Bladder Outlet | Obstruction at bladder neck or proximal urethra; overdistension damages detrusor; back-pressure affects both kidneys | Benign prostatic hyperplasia, prostate cancer, bladder cancer, neurogenic bladder, blood clots | Most common cause of postrenal acute kidney injury in elderly males; palpable bladder; large post-void residual |
| Urethral | Complete obstruction prevents any urine output; partial obstruction causes high-pressure voiding | Stricture, phimosis, meatal stenosis, posterior urethral valves (congenital) | May present with complete anuria; catheter placement diagnostic and therapeutic |
How Obstruction Causes Kidney Injury
Urinary obstruction triggers a cascade of events that progressively damage renal function:
- Early phase (hours): Increased intratubular pressure initially raises glomerular filtration rate transiently (renal vasodilation); then pressure equilibrates and filtration stops
- Intermediate phase (days): Afferent vasoconstriction occurs (mediated by angiotensin II, thromboxane); renal blood flow declines; tubular atrophy begins
- Late phase (weeks): Interstitial fibrosis, tubular loss, and irreversible nephron damage; even complete relief of obstruction may not restore function
Key point: Recovery potential depends on duration and completeness of obstruction. Relief within 1-2 weeks usually allows good recovery; obstruction lasting more than 4-6 weeks often causes permanent damage.
Often Overlooked Mechanism: Abdominal Compartment Syndrome
Elevated intra-abdominal pressure (greater than 20 mmHg with organ dysfunction) is an underrecognized cause of oliguria in critically ill patients. The mechanism involves:
- Direct compression of renal veins and parenchyma
- Reduced renal arterial flow due to elevated downstream pressure
- Decreased cardiac output from impaired venous return
Suspect in patients with massive fluid resuscitation, pancreatitis, abdominal trauma, or post-abdominal surgery. Bladder pressure measurement greater than 20 mmHg is diagnostic. Oliguria may be the first sign—decompression can be life-saving.
3. History Taking
A comprehensive approach to eliciting the oliguria history
Red Flags — Require Urgent Evaluation
- Complete anuria — Suggests complete obstruction or bilateral vascular occlusion
- Gross hematuria with clots — Risk of clot retention and obstruction
- Severe hyperkalemia symptoms — Muscle weakness, palpitations, chest pain
- Pulmonary edema symptoms — Acute dyspnea, orthopnea, pink frothy sputum
- Altered mental status — Uremic encephalopathy or severe electrolyte disturbance
- Recent exposure to nephrotoxins — Contrast within 72 hours, new medications
- Systemic symptoms with oliguria — Fever, rash, joint pain (suggests glomerulonephritis or vasculitis)
- Recent severe hypotension or cardiac arrest — High risk for acute tubular necrosis
- Dark brown or cola-colored urine — Suggests rhabdomyolysis or hemolysis
- Flank pain with oliguria — Consider obstruction, renal infarction, or pyelonephritis
Systematic History: The “VOLUME” Approach
Use the mnemonic “VOLUME” to ensure comprehensive history taking for oliguria:
- V — Volume status clues: Ask about fluid intake, losses (vomiting, diarrhea, bleeding, sweating), weight changes, and edema. “Have you been drinking less? Any vomiting or diarrhea? Have you noticed swelling in your legs?”
- O — Obstruction symptoms: Ask about urinary symptoms—difficulty starting stream, weak flow, incomplete emptying, dribbling, suprapubic fullness, flank pain. “Have you had trouble urinating? Any pain in your back or sides?”
- L — List of medications and exposures: Review all medications including over-the-counter drugs, supplements, contrast agents, and recent procedures. “What medications do you take? Any new ones? Any recent scans with dye?”
- U — Underlying conditions: Ask about diabetes, hypertension, heart failure, liver disease, kidney disease, autoimmune conditions, recent infections. “Do you have any chronic medical conditions?”
- M — Manifestations of systemic disease: Ask about fever, rash, joint pain, hemoptysis, sinusitis, oral ulcers, recent sore throat (suggests glomerulonephritis or vasculitis). “Any fevers, skin rashes, or joint pains?”
- E — Events and timeline: Establish precise onset and timeline. Was it sudden or gradual? What happened just before? Recent surgery, hospitalization, illness, or procedure? “When did you first notice less urine? What was happening around that time?”
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Hypovolemia / Dehydration | Thirst, dizziness on standing, reduced oral intake, losses | “Have you been eating and drinking normally? Any vomiting, diarrhea, or heavy sweating? Do you feel dizzy when you stand up?” |
| Heart failure | Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, leg swelling, weight gain | “Are you more short of breath than usual? How many pillows do you sleep with? Have your legs been more swollen? Have you gained weight recently?” |
| Sepsis | Fever, chills, rigors, localizing symptoms of infection | “Have you had fevers or chills? Any cough, painful urination, abdominal pain, or skin infections?” |
| Urinary obstruction | Difficulty voiding, weak stream, incomplete emptying, suprapubic discomfort | “Have you had trouble passing urine? Is your stream weaker than usual? Do you feel like your bladder doesn’t empty completely?” |
| Nephrotoxic acute tubular necrosis | Recent contrast, aminoglycosides, nonsteroidal anti-inflammatory drugs, chemotherapy | “Have you had any scans with contrast dye in the last few days? Are you taking any antibiotics, pain medications like ibuprofen, or chemotherapy?” |
| Rhabdomyolysis | Muscle pain, weakness, dark urine, recent trauma, immobilization, extreme exertion, drug use | “Have you had any muscle pain or weakness? Is your urine dark like cola or tea? Any recent falls, prolonged immobility, intense exercise, or drug use?” |
| Glomerulonephritis | Hematuria, foamy urine, periorbital edema, recent infection, systemic symptoms | “Have you noticed blood in your urine or foamy urine? Any swelling around your eyes? Have you had a sore throat or skin infection recently? Any joint pains or rashes?” |
| Acute interstitial nephritis | New medication in past 1-3 weeks, fever, rash, eosinophilia | “Have you started any new medications in the last few weeks? Any fevers or skin rash?” |
| Hepatorenal syndrome | Known cirrhosis, ascites, recent large-volume paracentesis, gastrointestinal bleeding | “Do you have liver disease or cirrhosis? Has your belly been getting bigger? Have you had fluid drained recently or any vomiting of blood?” |
| Thrombotic microangiopathy | Bloody diarrhea (hemolytic uremic syndrome), neurological symptoms, pregnancy/postpartum | “Have you had bloody diarrhea recently? Any confusion, headaches, or vision changes? Are you pregnant or recently gave birth?” |
Medication and Exposure History
Medications That Cause or Worsen Oliguria
- Nonsteroidal anti-inflammatory drugs (NSAIDs) — Inhibit prostaglandin-mediated afferent arteriolar vasodilation; particularly dangerous in volume depletion
- Angiotensin-converting enzyme (ACE) inhibitors / Angiotensin receptor blockers (ARBs) — Reduce efferent arteriolar tone; problematic in bilateral renal artery stenosis or hypovolemia
- Aminoglycosides — Direct tubular toxicity; accumulates with repeated dosing; typically occurs after 5-7 days
- Vancomycin — Tubular toxicity, especially at high trough levels or with concurrent nephrotoxins
- Amphotericin B — Dose-dependent tubular and vascular toxicity
- Contrast media — Tubular toxicity and vasoconstriction; risk peaks 48-72 hours post-exposure
- Calcineurin inhibitors (cyclosporine, tacrolimus) — Afferent arteriolar vasoconstriction; dose-dependent
- Proton pump inhibitors — Acute interstitial nephritis (often delayed weeks to months)
- Diuretics — Can cause prerenal azotemia if excessive; thiazides can cause interstitial nephritis
- Chemotherapy agents — Cisplatin, methotrexate, ifosfamide cause direct tubular injury
Important Exposure History
- Recent procedures: Angiography, cardiac catheterization, contrast-enhanced computed tomography (timing relative to oliguria onset)
- Recent surgery: Especially cardiac surgery, aortic procedures, prolonged operations with hypotension
- Hospitalizations: Intensive care unit stays, sepsis episodes, periods of hypotension
- Supplements and herbal products: Creatine, weight loss supplements, herbal remedies (may contain nephrotoxins)
- Recreational drugs: Cocaine (rhabdomyolysis, vasoconstriction), heroin, synthetic cannabinoids, MDMA (ecstasy)
- Occupational exposures: Heavy metals (lead, mercury), organic solvents, ethylene glycol
- Dietary factors: Excessive protein intake, star fruit (neurotoxic in kidney disease), high oxalate foods
Recent Illness History
- Upper respiratory infection 1-3 weeks prior — Post-streptococcal glomerulonephritis, immunoglobulin A nephropathy
- Gastroenteritis with bloody diarrhea — Hemolytic uremic syndrome (especially with Escherichia coli O157:H7)
- Skin infection — Post-infectious glomerulonephritis
Quantifying and Characterizing Urine Output
| Question | Why It Matters | Clinical Significance |
|---|---|---|
| “When did you last urinate normally?” | Establishes timeline and acuity | Sudden onset suggests obstruction or vascular event; gradual decline suggests prerenal or intrinsic causes |
| “How many times a day are you urinating now versus before?” | Quantifies change from baseline | Reduced frequency with small volumes suggests oliguria; frequency with small volumes suggests obstruction with overflow |
| “What color is your urine?” | Suggests etiology | Dark concentrated = dehydration; cola/tea-colored = myoglobin/hemoglobin; red/pink = hematuria; cloudy = infection |
| “Is your urine foamy?” | Suggests proteinuria | Persistent foam indicates significant proteinuria; consider glomerular disease |
| “Any pain with urination or in your back/sides?” | Localizes pathology | Dysuria = infection or inflammation; flank pain = obstruction, pyelonephritis, or renal infarction |
Critical Past Medical History Elements
Conditions that increase risk:
- Pre-existing chronic kidney disease (reduced renal reserve)
- Diabetes mellitus (nephropathy, increased infection risk)
- Hypertension (nephrosclerosis, renovascular disease)
- Heart failure (cardiorenal syndrome)
- Cirrhosis (hepatorenal syndrome risk)
- Multiple myeloma (cast nephropathy, hypercalcemia)
- Autoimmune diseases (lupus, vasculitis)
Urological history:
- Benign prostatic hyperplasia (obstruction risk)
- Previous kidney stones (recurrent obstruction)
- Urological malignancy (obstruction)
- Previous urological surgery
- Single kidney (any insult affects all function)
- Neurogenic bladder (retention risk)
- Recurrent urinary tract infections
4. Physical Examination
A systematic head-to-toe approach for oliguria
Systematic Framework: The physical examination in oliguria serves three primary goals: (1) Assess volume status—is the patient hypovolemic, euvolemic, or hypervolemic? (2) Identify the underlying cause—prerenal, intrinsic, or postrenal? (3) Detect complications—pulmonary edema, pericarditis, encephalopathy. Use a systematic “Volume-Cause-Complications” approach.
General Inspection
- Overall appearance: Alert versus confused or drowsy (uremic encephalopathy, electrolyte disturbance); comfortable versus distressed
- Skin color: Pallor (anemia of chronic kidney disease, hemolysis); jaundice (hepatorenal syndrome); uremic frost (rare, indicates severe prolonged uremia)
- Respiratory pattern: Kussmaul breathing (deep, rapid—metabolic acidosis); labored breathing (pulmonary edema)
- Hydration status at first glance: Dry mucous membranes, sunken eyes (dehydration) versus facial/periorbital edema (fluid overload or nephrotic syndrome)
- Signs of chronic kidney disease: Excoriations from pruritus, pallor, muscle wasting, brown discoloration of nails (Lindsay’s nails)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Hypotension (systolic less than 90 mmHg or mean arterial pressure less than 65 mmHg); severe hypertension; orthostatic changes | Hypotension suggests prerenal cause (hypovolemia, sepsis, cardiogenic); severe hypertension suggests glomerulonephritis, malignant hypertension, or scleroderma renal crisis |
| Orthostatic Vitals | Drop in systolic blood pressure greater than 20 mmHg or heart rate increase greater than 20 beats per minute on standing | Positive orthostatics suggest volume depletion (sensitivity approximately 30%, but high specificity when positive) |
| Heart Rate | Tachycardia; bradycardia; irregular rhythm | Tachycardia suggests hypovolemia, sepsis, or heart failure; bradycardia may indicate severe hyperkalemia; arrhythmias suggest electrolyte disturbance |
| Temperature | Fever; hypothermia | Fever suggests infection (sepsis, pyelonephritis) or inflammatory condition (interstitial nephritis, vasculitis); hypothermia can occur in severe sepsis |
| Respiratory Rate | Tachypnea; Kussmaul respiration | Tachypnea suggests pulmonary edema, metabolic acidosis compensation, or underlying pulmonary pathology |
| Oxygen Saturation | Hypoxia (saturation less than 94% on room air) | May indicate pulmonary edema from volume overload; also consider pulmonary-renal syndromes (Goodpasture syndrome, granulomatosis with polyangiitis) |
Volume Status Assessment: The Critical Determination
| Finding | Hypovolemia | Euvolemia | Hypervolemia |
|---|---|---|---|
| Jugular venous pressure | Low or not visible (less than 3 cm above sternal angle) | Normal (3-4 cm above sternal angle at 45 degrees) | Elevated (greater than 4 cm); hepatojugular reflux positive |
| Skin turgor | Decreased (skin tenting, especially over clavicle) | Normal | Normal or edematous |
| Mucous membranes | Dry, sticky | Moist | Moist |
| Axillae | Dry (normally moist) | Moist | Moist |
| Peripheral edema | Absent | Absent | Present (pitting edema of ankles, sacrum if bedridden) |
| Lung examination | Clear | Clear | Crackles (pulmonary edema), pleural effusions (dullness at bases) |
| Capillary refill | Prolonged (greater than 3 seconds) | Normal (less than 2 seconds) | Normal or prolonged if cardiac output reduced |
Clinical Pearl: The Passive Leg Raise Test
In patients where volume status is uncertain, the passive leg raise test can help predict fluid responsiveness:
- With patient supine, raise both legs to 45 degrees for 1-2 minutes
- This autotransfuses approximately 300-500 mL from lower extremities to central circulation
- An increase in cardiac output or blood pressure suggests the patient will respond to fluid administration
- More reliable than static measures (jugular venous pressure, central venous pressure) in predicting fluid responsiveness
Cardiovascular Examination
Inspection and Palpation
- Jugular venous pressure: Assess at 45 degrees; measure height above sternal angle; look for hepatojugular reflux
- Apex beat: Displaced laterally in cardiomegaly (heart failure); heaving quality in left ventricular hypertrophy
- Peripheral pulses: Weak and thready in hypovolemia or low cardiac output; bounding in hyperdynamic states
- Peripheral edema: Assess ankles, shins, sacrum; quantify as mild, moderate, or severe (or grade 1-4+)
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Third heart sound (S3 gallop) | Low-pitched sound in early diastole; best heard at apex with bell | Volume overload, heart failure, cardiomyopathy—suggests elevated filling pressures |
| Fourth heart sound (S4) | Low-pitched sound just before S1; indicates atrial contraction against stiff ventricle | Left ventricular hypertrophy, hypertensive heart disease, ischemia |
| Pericardial friction rub | Scratchy, triphasic sound; best heard with patient leaning forward | Uremic pericarditis—indicates need for urgent dialysis |
| New murmur | May be systolic (mitral regurgitation) or diastolic | Endocarditis (consider if fever present); ischemic mitral regurgitation |
Respiratory Examination
Inspection
- Respiratory distress: Use of accessory muscles, tripod positioning, inability to speak full sentences
- Respiratory pattern: Kussmaul breathing (metabolic acidosis); Cheyne-Stokes (uremic encephalopathy or heart failure)
Auscultation
| Finding | Description | Clinical Significance |
|---|---|---|
| Bilateral basal crackles | Fine, inspiratory crackles at lung bases that do not clear with coughing | Pulmonary edema from volume overload—requires urgent management |
| Decreased breath sounds at bases | Reduced air entry with dullness to percussion | Pleural effusions (may be bilateral in volume overload or nephrotic syndrome) |
| Diffuse crackles or hemorrhagic findings | Bilateral crackles, hemoptysis | Pulmonary-renal syndrome (Goodpasture syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis) |
Abdominal Examination
Inspection
- Distension: Ascites (cirrhosis, nephrotic syndrome); massive bladder (urinary retention)
- Surgical scars: Previous kidney transplant, urological surgery
- Visible masses: Polycystic kidneys may be visible in thin patients
Palpation
- Bladder: Palpable above pubic symphysis suggests urinary retention; dull to percussion
- Kidneys: Normally not palpable; enlarged in polycystic kidney disease, hydronephrosis, or tumor
- Liver: Hepatomegaly with pulsatility suggests right heart failure; firm nodular liver suggests cirrhosis
- Ascites: Shifting dullness, fluid thrill; suggests cirrhosis, nephrotic syndrome, or heart failure
- Tenderness: Costovertebral angle tenderness suggests pyelonephritis or renal calculus; suprapubic tenderness in bladder pathology
- Abdominal compartment syndrome: Tense, distended abdomen; measure bladder pressure if suspected (greater than 20 mmHg with organ dysfunction is diagnostic)
Auscultation
- Renal artery bruits: Listen in epigastrium and flanks; suggests renovascular disease (sensitivity low, approximately 40%)
- Femoral bruits: Suggest peripheral vascular disease; atherosclerosis may affect renal arteries
Genitourinary Examination
- Bladder assessment: Palpate for distended bladder; if in doubt, perform bedside bladder scan or catheterize
- Digital rectal examination (in males): Assess prostate size, nodularity, tenderness; enlarged prostate suggests benign prostatic hyperplasia
- External genitalia: Phimosis, meatal stenosis, urethral discharge (may suggest obstruction or infection)
- Foley catheter (if present): Check for kinks, obstruction; flush to confirm patency; note urine color and clarity
Skin Examination
| Finding | Description | Associated Conditions |
|---|---|---|
| Purpura/petechiae | Non-blanching red or purple spots | Vasculitis, thrombotic microangiopathy, endocarditis |
| Livedo reticularis | Lacy, net-like reddish-blue pattern on skin | Cholesterol emboli syndrome, vasculitis, antiphospholipid syndrome |
| Malar (butterfly) rash | Erythematous rash over cheeks and nasal bridge | Systemic lupus erythematosus (lupus nephritis) |
| Palpable purpura | Raised purpuric lesions, especially on lower extremities | Small vessel vasculitis (immunoglobulin A vasculitis, cryoglobulinemia) |
| Drug rash | Maculopapular eruption, often with eosinophilia and fever | Acute interstitial nephritis (drug reaction with eosinophilia and systemic symptoms) |
| Track marks | Injection sites on arms | Intravenous drug use—consider endocarditis, hepatitis C-associated glomerulonephritis |
Neurological Examination
- Mental status: Confusion, asterixis (flapping tremor of outstretched hands), drowsiness, seizures suggest uremic encephalopathy or severe electrolyte disturbance
- Asterixis: Have patient extend arms with wrists dorsiflexed; positive if hands “flap” downward—indicates metabolic encephalopathy
- Deep tendon reflexes: Hyporeflexia may indicate hyperkalemia or uremia; hyperreflexia in hypocalcemia
- Peripheral neuropathy: Sensory loss in stocking-glove distribution suggests diabetic nephropathy or uremic neuropathy
- Focal deficits: Consider thrombotic microangiopathy, vasculitis, or hypertensive emergency with posterior reversible encephalopathy syndrome
Extremities
- Edema: Pitting edema of ankles and legs (volume overload); may extend to thighs and sacrum in severe cases
- Muscle tenderness: Diffuse tenderness suggests rhabdomyolysis; check for compartment syndrome
- Arteriovenous fistula: If present, assess for thrill and bruit; indicates known dialysis-dependent kidney disease
- Peripheral pulses: Absent or diminished suggests peripheral vascular disease (may indicate renal artery stenosis)
- Capillary refill: Greater than 3 seconds suggests poor perfusion
- Cyanosis: Peripheral cyanosis in poor perfusion; central cyanosis in hypoxia
Expected Findings by Etiology
| Condition | Volume Status | Key Examination Findings | Additional Clues |
|---|---|---|---|
| Hypovolemia / Dehydration | Hypovolemic | Dry mucous membranes, decreased skin turgor, low jugular venous pressure, tachycardia, orthostatic hypotension | May have obvious source of loss (vomiting, diarrhea, bleeding) |
| Heart failure (cardiorenal syndrome) | Hypervolemic | Elevated jugular venous pressure, S3 gallop, displaced apex, bilateral crackles, peripheral edema | May have known cardiac history; bilateral pleural effusions common |
| Sepsis | Variable (often hypovolemic) | Fever or hypothermia, tachycardia, tachypnea, warm peripheries (early) or cold peripheries (late/shock) | Look for source: pneumonia, cellulitis, abdominal findings |
| Urinary obstruction (bladder outlet) | Usually euvolemic | Palpable bladder, enlarged prostate on rectal examination | History of prostatic symptoms; may have overflow incontinence |
| Acute glomerulonephritis | Euvolemic or hypervolemic | Hypertension, periorbital edema, peripheral edema; may have rash, joint swelling, or other systemic features | Cola-colored urine; recent infection history; systemic symptoms |
| Acute tubular necrosis | Variable | Often no specific findings; reflects underlying cause (sepsis, hypotension, toxic exposure) | History of prolonged hypotension, nephrotoxin exposure, or sepsis |
| Hepatorenal syndrome | Hypervolemic (ascites) but decreased effective circulating volume | Jaundice, ascites, spider angiomata, palmar erythema, caput medusae, asterixis | Known cirrhosis; may be precipitated by infection or large-volume paracentesis |
| Rhabdomyolysis | Often hypovolemic (third-spacing into muscle) | Muscle tenderness, swelling, weakness; dark urine | History of trauma, immobilization, extreme exertion, drug use, or statins |
Important Teaching Point
Clinical examination has limitations in assessing volume status! Studies show that clinical assessment of volume status is accurate only 50-70% of the time, even among experienced clinicians. Key points to remember:
- Peripheral edema can be present even with intravascular volume depletion (e.g., nephrotic syndrome, cirrhosis)
- Jugular venous pressure can be difficult to assess in obese patients or those with short necks
- When in doubt, integrate clinical findings with laboratory data (blood urea nitrogen-to-creatinine ratio, urine sodium, fractional excretion of sodium) and consider dynamic tests (passive leg raise, fluid challenge with monitoring)
- Point-of-care ultrasound (inferior vena cava collapsibility, lung ultrasound for B-lines) is increasingly used to complement clinical examination
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The Fundamental Question: Is this prerenal, intrinsic renal, or postrenal?
This classification determines initial management and urgency. Always consider postrenal obstruction first—it is the most rapidly reversible cause if identified early, but causes irreversible damage if missed.
Overall Etiology Distribution in Acute Kidney Injury
| Category | Frequency | Key Feature | Typical Fractional Excretion of Sodium |
|---|---|---|---|
| Prerenal | 55-60% | Reduced renal perfusion with intact tubular function | Less than 1% |
| Intrinsic Renal | 35-40% | Structural damage to kidney parenchyma | Greater than 2% (usually) |
| Postrenal | 5-10% | Obstruction to urine outflow | Variable |
Prerenal Causes (55-60% of Acute Kidney Injury)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Hypovolemia (dehydration, hemorrhage, gastrointestinal losses) | History of reduced intake, vomiting, diarrhea, bleeding; orthostatic hypotension; dry mucous membranes | Massive hemorrhage; hemodynamic instability |
| COMMON | Sepsis and septic shock | Fever, hypotension, tachycardia, identified infection source; may have warm peripheries early | Refractory hypotension; lactate greater than 4 mmol/L; multiorgan dysfunction |
| COMMON | Heart failure (cardiorenal syndrome) | Dyspnea, orthopnea, elevated jugular venous pressure, S3 gallop, peripheral edema, pulmonary crackles | Acute pulmonary edema; cardiogenic shock; new arrhythmia |
| LESS COMMON | Hepatorenal syndrome | Known cirrhosis, ascites, jaundice; often precipitated by infection or large-volume paracentesis | Type 1 hepatorenal syndrome (rapid progression); concurrent spontaneous bacterial peritonitis |
| LESS COMMON | Medication-induced renal hypoperfusion | Recent initiation of nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or calcineurin inhibitors | Bilateral renal artery stenosis with angiotensin-converting enzyme inhibitor use |
| UNCOMMON BUT SERIOUS | Abdominal compartment syndrome | Tense distended abdomen; recent massive fluid resuscitation, pancreatitis, or abdominal surgery | Bladder pressure greater than 20 mmHg with organ dysfunction; respiratory compromise |
Intrinsic Renal Causes (35-40% of Acute Kidney Injury)
Step-by-Step Approach to Intrinsic Acute Kidney Injury:
- Step 1: Is this acute tubular necrosis? — Most common intrinsic cause (approximately 85% of intrinsic acute kidney injury); look for ischemic or nephrotoxic etiology
- Step 2: Is there evidence of glomerulonephritis? — Active urine sediment (red blood cell casts, dysmorphic red blood cells), proteinuria, systemic features
- Step 3: Consider acute interstitial nephritis — Recent new medication, fever, rash, eosinophilia
- Step 4: Evaluate for vascular causes — Flank pain, livedo reticularis, recent vascular procedure
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Acute tubular necrosis — Ischemic | 45% of intrinsic | Follows prolonged hypotension, sepsis, or major surgery; muddy brown granular casts; fractional excretion of sodium greater than 2% |
| COMMON | Acute tubular necrosis — Nephrotoxic | 35% of intrinsic | Aminoglycosides (after 5-7 days), contrast (48-72 hours post-exposure), vancomycin, amphotericin B |
| LESS COMMON | Acute interstitial nephritis | 10-15% of intrinsic | New medication 1-3 weeks prior; classic triad of fever, rash, eosinophilia (present in only 10-30%); white blood cell casts, sterile pyuria |
| LESS COMMON | Pigment nephropathy (rhabdomyolysis) | 5-10% of intrinsic | Muscle pain, weakness, dark tea/cola-colored urine; creatine kinase greater than 5,000 units/L; positive urine myoglobin |
| LESS COMMON | Pigment nephropathy (hemolysis) | Less than 5% of intrinsic | Transfusion reaction, mechanical heart valve, paroxysmal nocturnal hemoglobinuria; elevated lactate dehydrogenase, low haptoglobin, pink plasma |
| UNCOMMON BUT SERIOUS | Rapidly progressive glomerulonephritis | Less than 5% of intrinsic | Red blood cell casts, dysmorphic red blood cells, proteinuria; may have systemic symptoms (hemoptysis, rash, arthritis); creatinine doubles in weeks |
| UNCOMMON BUT SERIOUS | Thrombotic microangiopathy (thrombotic thrombocytopenic purpura / hemolytic uremic syndrome) | Less than 5% of intrinsic | Microangiopathic hemolytic anemia (schistocytes), thrombocytopenia; neurological symptoms in thrombotic thrombocytopenic purpura; bloody diarrhea in typical hemolytic uremic syndrome |
| UNCOMMON BUT SERIOUS | Atheroembolic disease (cholesterol emboli) | Less than 5% of intrinsic | Recent vascular procedure or anticoagulation; livedo reticularis, blue toe syndrome; eosinophilia, hypocomplementemia |
| UNCOMMON BUT SERIOUS | Acute cortical necrosis | Rare | Severe hypotension, obstetric catastrophe, severe sepsis; prolonged anuria; often irreversible |
Postrenal Causes (5-10% of Acute Kidney Injury)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Benign prostatic hyperplasia (bladder outlet obstruction) | Elderly male; weak stream, hesitancy, nocturia, incomplete emptying; palpable bladder; enlarged prostate on examination | Complete urinary retention; overflow incontinence |
| LESS COMMON | Urolithiasis (bilateral or solitary kidney) | Severe colicky flank pain radiating to groin; hematuria; history of stones | Infected obstructed system (pyonephrosis); solitary kidney |
| LESS COMMON | Malignancy (bladder, prostate, cervical, colorectal) | Gradual onset; weight loss; may have pelvic mass; bilateral hydronephrosis on imaging | Complete obstruction; bilateral ureteral involvement |
| LESS COMMON | Neurogenic bladder | Diabetes, spinal cord disease, multiple sclerosis, stroke; large post-void residual | Recurrent urinary tract infections; large residual volumes |
| UNCOMMON | Retroperitoneal fibrosis | Bilateral ureteral obstruction; may have abdominal/back pain; associated with drugs (ergots, beta-blockers), malignancy, or idiopathic | Progressive obstruction; may encase ureters |
| UNCOMMON | Blood clots (clot retention) | Gross hematuria; bladder distension; often post-procedure or with bladder/prostate malignancy | Complete obstruction; hemodynamic instability from bleeding |
| UNCOMMON | Iatrogenic (surgical ligation or injury) | Post-pelvic or urological surgery; immediate postoperative oliguria | Complete anuria post-surgery suggests bilateral injury |
Anatomical Approach to Oliguria
Prerenal (Before the Kidney)
Hypovolemia (hemorrhage, dehydration, burns)
Decreased cardiac output (heart failure, tamponade)
Systemic vasodilation (sepsis, anaphylaxis)
Renal vasoconstriction (hepatorenal syndrome, nonsteroidal anti-inflammatory drugs)
Renal artery stenosis / occlusion
Glomerular
Rapidly progressive glomerulonephritis
Anti-glomerular basement membrane disease
Lupus nephritis
Immunoglobulin A nephropathy (crescentic)
Anti-neutrophil cytoplasmic antibody-associated vasculitis
Post-infectious glomerulonephritis
Tubular and Interstitial
Acute tubular necrosis (ischemic, nephrotoxic)
Acute interstitial nephritis (drug-induced)
Pigment nephropathy (myoglobin, hemoglobin)
Myeloma cast nephropathy
Crystal nephropathy (uric acid, acyclovir)
Tumor lysis syndrome
Postrenal (After the Kidney)
Bladder outlet: benign prostatic hyperplasia, cancer, stricture
Ureteral: stones, malignancy, retroperitoneal fibrosis
Urethral: stricture, phimosis
Intratubular: crystals, casts
Blood clots
Drug-Induced Oliguria and Acute Kidney Injury
| Drug or Drug Class | Mechanism | Characteristics | Time to Onset / Resolution |
|---|---|---|---|
| Nonsteroidal anti-inflammatory drugs | Inhibit prostaglandin-mediated afferent arteriolar vasodilation (prerenal); can also cause interstitial nephritis | Especially dangerous in hypovolemia, heart failure, chronic kidney disease; reversible with cessation | Days to weeks / Usually resolves within 1-2 weeks of stopping |
| Angiotensin-converting enzyme inhibitors / Angiotensin receptor blockers | Inhibit angiotensin II-mediated efferent arteriolar constriction; reduce glomerular filtration pressure | Dangerous in bilateral renal artery stenosis, hypovolemia, or concurrent nonsteroidal anti-inflammatory drug use | Days / Usually resolves within 1 week of stopping |
| Aminoglycosides (gentamicin, tobramycin, amikacin) | Direct proximal tubular toxicity; accumulates in tubular cells | Non-oliguric acute kidney injury common; typically after 5-7 days of therapy; dose and duration dependent | 5-7 days / Weeks to months for recovery |
| Vancomycin | Tubular toxicity; oxidative stress; may cause interstitial nephritis | Risk increases with trough greater than 20 mcg/mL, prolonged duration, concurrent nephrotoxins | Days to weeks / Usually reversible over weeks |
| Iodinated contrast media | Direct tubular toxicity and renal vasoconstriction | Peak creatinine at 48-72 hours; risk factors: chronic kidney disease, diabetes, volume depletion, high contrast volume | 24-72 hours / Usually resolves within 7-14 days |
| Amphotericin B (conventional) | Direct tubular toxicity; renal vasoconstriction | Dose-dependent; hypokalemia and hypomagnesemia common; lipid formulations less nephrotoxic | Days to weeks / May be slow or incomplete recovery |
| Calcineurin inhibitors (cyclosporine, tacrolimus) | Afferent arteriolar vasoconstriction; chronic use causes interstitial fibrosis | Dose-dependent; reversible with dose reduction; potentiated by volume depletion | Days / Reversible with dose adjustment |
| Proton pump inhibitors | Acute interstitial nephritis (idiosyncratic) | May occur weeks to months after starting; often without classic rash/eosinophilia | Weeks to months / Usually resolves over weeks after stopping |
| Chemotherapy (cisplatin, methotrexate) | Direct tubular toxicity (cisplatin); crystal nephropathy (methotrexate) | Cisplatin: cumulative, dose-dependent; Methotrexate: prevented with hydration and alkalinization | Days / Variable; cisplatin may be irreversible |
| Acyclovir / Valacyclovir | Crystal precipitation in tubules | Risk with high doses, rapid infusion, volume depletion; crystals visible in urine | Hours to days / Usually reversible with hydration |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Elderly male with weak stream and palpable bladder | Bladder outlet obstruction (benign prostatic hyperplasia) | Bladder scan or catheterization; measure post-void residual |
| Oliguria 48-72 hours after contrast exposure | Contrast-induced nephropathy | Supportive care; usually self-limited; avoid further nephrotoxins |
| Hypotension, fever, elevated lactate | Sepsis-associated acute kidney injury | Fluid resuscitation, source control, antibiotics; monitor for progression to acute tubular necrosis |
| Dark cola-colored urine with muscle pain | Rhabdomyolysis | Check creatine kinase; aggressive intravenous fluids; monitor for hyperkalemia |
| Red blood cell casts, hematuria, hypertension | Glomerulonephritis (acute or rapidly progressive) | Urgent nephrology consultation; serologies (anti-nuclear antibody, anti-neutrophil cytoplasmic antibody, complement, anti-glomerular basement membrane); consider biopsy |
| New medication 1-3 weeks ago with fever or rash | Acute interstitial nephritis | Stop offending drug; check urine eosinophils; consider steroids if severe |
| Known cirrhosis with worsening ascites and oliguria | Hepatorenal syndrome | Rule out infection (paracentesis); volume challenge; consider vasoconstrictors and albumin |
| Schistocytes, thrombocytopenia, neurological symptoms | Thrombotic thrombocytopenic purpura | Urgent hematology consultation; plasma exchange; do NOT transfuse platelets |
| Bloody diarrhea followed by acute kidney injury (especially in child) | Hemolytic uremic syndrome (Shiga toxin-associated) | Supportive care; avoid antibiotics; nephrology consultation |
| Complete anuria | Complete obstruction or bilateral vascular occlusion | Urgent bladder catheterization and renal ultrasound; if normal, consider vascular imaging |
| Livedo reticularis after cardiac catheterization | Cholesterol emboli syndrome | Supportive care; eosinophilia and hypocomplementemia may be present; poor prognosis |
Special Populations: Modified Differential
Hospitalized / Intensive Care Unit Patients:
- Sepsis (most common cause)
- Nephrotoxic medications
- Contrast-induced nephropathy
- Postoperative hypoperfusion
- Abdominal compartment syndrome
Outpatient / Community Setting:
- Dehydration / volume depletion
- Heart failure exacerbation
- Medication-related (nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors)
- Urinary obstruction (benign prostatic hyperplasia)
- Acute glomerulonephritis (if active sediment)
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Investigation Priorities in Oliguria:
- Immediate: Assess for obstruction (bladder scan/catheterization, renal ultrasound)
- Early: Determine prerenal versus intrinsic (urine studies, serum creatinine trend)
- Targeted: Identify specific cause based on clinical suspicion
Baseline Investigations for All Patients with Oliguria
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Serum creatinine and blood urea nitrogen | Assess kidney function and trend | Rate of rise; blood urea nitrogen-to-creatinine ratio greater than 20:1 suggests prerenal | Compare to baseline; creatinine lags behind true glomerular filtration rate decline by 24-48 hours |
| Electrolytes (sodium, potassium, chloride, bicarbonate) | Detect life-threatening abnormalities | Hyperkalemia (greater than 5.5 mEq/L), metabolic acidosis (low bicarbonate), hyponatremia | Urgent electrocardiogram if potassium greater than 6.0 mEq/L or symptoms present |
| Complete blood count | Assess for anemia, infection, thrombocytopenia | Anemia (hemolysis, chronic kidney disease); leukocytosis (infection); thrombocytopenia (thrombotic microangiopathy, sepsis) | Request peripheral smear if thrombocytopenia to look for schistocytes |
| Urinalysis with microscopy | Critical for differentiating causes | Specific gravity, protein, blood, white blood cells, casts (see interpretation below) | Fresh sample essential; examine sediment within 30-60 minutes |
| Urine sodium and creatinine | Calculate fractional excretion of sodium | Urine sodium less than 20 mEq/L suggests prerenal; greater than 40 mEq/L suggests intrinsic | Collect before giving diuretics (invalidates results) |
| Bladder scan or catheterization | Rule out urinary retention | Post-void residual greater than 200-300 mL significant; greater than 500 mL indicates retention | Quick, non-invasive; if retention found, leave catheter and monitor output |
| Renal ultrasound | Detect obstruction (hydronephrosis), assess kidney size | Bilateral hydronephrosis suggests lower tract obstruction; unilateral suggests ureteral obstruction | Can be done at bedside; absence of hydronephrosis does not fully exclude obstruction in early or dehydrated states |
| Electrocardiogram | Assess for hyperkalemia effects | Peaked T waves, widened QRS, sine wave pattern | Urgent if potassium greater than 6.0 mEq/L; electrocardiogram changes may precede cardiac arrest |
Urinalysis and Urine Sediment Interpretation
| Finding | Interpretation | Suggests |
|---|---|---|
| High specific gravity (greater than 1.020) | Concentrated urine; intact tubular concentrating ability | Prerenal azotemia |
| Low specific gravity (approximately 1.010, isosthenuria) | Dilute urine; impaired tubular concentrating ability | Intrinsic renal disease (acute tubular necrosis) |
| Muddy brown granular casts | Degenerating tubular epithelial cells | Acute tubular necrosis (highly specific) |
| Red blood cell casts | Glomerular bleeding with cast formation | Glomerulonephritis (pathognomonic) |
| Dysmorphic red blood cells | Red blood cells damaged traversing glomerular basement membrane | Glomerular disease |
| White blood cell casts | White blood cells originating from tubules | Acute interstitial nephritis, pyelonephritis |
| Eosinophiluria | Eosinophils in urine (Hansel stain) | Acute interstitial nephritis (sensitivity approximately 40%, specificity approximately 70%); also cholesterol emboli |
| Hyaline casts | Precipitated Tamm-Horsfall protein | Non-specific; can be seen in prerenal states and concentrated urine |
| Pigmented granular casts | Myoglobin or hemoglobin | Rhabdomyolysis, hemolysis |
| Crystals | Various types depending on drug or metabolic disorder | Uric acid (tumor lysis), calcium oxalate (ethylene glycol), needle-shaped (acyclovir) |
Distinguishing Prerenal from Intrinsic Acute Kidney Injury
| Parameter | Prerenal Azotemia | Intrinsic (Acute Tubular Necrosis) | Notes |
|---|---|---|---|
| Urine sodium (mEq/L) | Less than 20 | Greater than 40 | Diuretics invalidate; may be low in contrast nephropathy, rhabdomyolysis, early sepsis |
| Fractional excretion of sodium (%) | Less than 1% | Greater than 2% | Formula: (Urine Na × Serum Cr) / (Serum Na × Urine Cr) × 100 |
| Fractional excretion of urea (%) | Less than 35% | Greater than 50% | More reliable if patient on diuretics |
| Urine osmolality (mOsm/kg) | Greater than 500 | Less than 350 (isosthenuria) | Reflects concentrating ability |
| Urine specific gravity | Greater than 1.020 | Approximately 1.010 | Quick bedside assessment |
| Blood urea nitrogen-to-creatinine ratio | Greater than 20:1 | 10-15:1 | Elevated ratio also seen with gastrointestinal bleeding, steroids, high protein intake |
| Urine sediment | Bland or hyaline casts | Muddy brown granular casts, epithelial cell casts | Sediment examination is key |
| Response to fluid challenge | Urine output increases | No significant response | Fluid challenge should be monitored carefully |
When Fractional Excretion of Sodium Can Be Misleading
Fractional excretion of sodium less than 1% does NOT always mean prerenal:
- Contrast-induced nephropathy — Tubular injury with preserved sodium reabsorption
- Rhabdomyolysis — Early phase before tubular damage
- Early sepsis — Before progression to acute tubular necrosis
- Acute glomerulonephritis — Reduced glomerular filtration rate with intact tubules
- Urinary obstruction — Early phase
In these cases, use fractional excretion of urea (less affected by tubular function) or clinical context.
Targeted Investigations by Suspected Etiology
If Suspecting Glomerulonephritis
First-Line Tests
- Urinalysis with microscopy: Red blood cell casts, dysmorphic red blood cells, proteinuria
- Spot urine protein-to-creatinine ratio: Quantifies proteinuria; greater than 3.5 g/g = nephrotic range
- Serum complement levels (C3, C4): Low in lupus, post-infectious glomerulonephritis, membranoproliferative glomerulonephritis
- Anti-nuclear antibody: Screening for systemic lupus erythematosus
Second-Line Tests
- Anti-neutrophil cytoplasmic antibody (cytoplasmic and perinuclear patterns): Granulomatosis with polyangiitis, microscopic polyangiitis
- Anti-glomerular basement membrane antibody: Goodpasture syndrome
- Anti-double stranded DNA, anti-Smith antibodies: If lupus suspected
- Hepatitis B and C serologies: Associated with membranous nephropathy, cryoglobulinemia
- Cryoglobulins: If cryoglobulinemic vasculitis suspected
- Kidney biopsy: Often required for definitive diagnosis and to guide treatment
If Suspecting Acute Interstitial Nephritis
First-Line Tests
- Complete blood count with differential: Eosinophilia (present in only 30-40%)
- Urinalysis: Sterile pyuria, white blood cell casts
- Urine eosinophils (Hansel stain): Supportive but not sensitive (approximately 40%) or specific
Second-Line Tests
- Gallium scan or positron emission tomography: Shows increased renal uptake (inflammation)
- Kidney biopsy: Gold standard; shows interstitial infiltrate with eosinophils
If Suspecting Rhabdomyolysis
First-Line Tests
- Creatine kinase: Typically greater than 5,000 units/L (often greater than 10,000-50,000); peak at 24-72 hours
- Urine myoglobin: Positive; note that dipstick shows “blood” but no red blood cells on microscopy
- Electrolytes: Hyperkalemia, hyperphosphatemia, hypocalcemia (early), hypercalcemia (recovery phase)
Additional Considerations
- Lactate dehydrogenase, aspartate aminotransferase: Elevated from muscle injury
- Uric acid: Often elevated
- Compartment pressure measurement: If compartment syndrome suspected
- Toxicology screen: If drug-induced suspected
If Suspecting Thrombotic Microangiopathy
First-Line Tests
- Peripheral blood smear: Schistocytes (fragmented red blood cells)
- Lactate dehydrogenase: Elevated (hemolysis marker)
- Haptoglobin: Low or undetectable (hemolysis)
- Reticulocyte count: Elevated (bone marrow response)
- Direct Coombs test: Negative (rules out autoimmune hemolysis)
Distinguishing Tests
- ADAMTS13 activity: Less than 10% in thrombotic thrombocytopenic purpura
- Stool culture for Shiga toxin / Escherichia coli O157:H7: Typical hemolytic uremic syndrome
- Complement studies (factor H, I, B): Atypical hemolytic uremic syndrome
- Pregnancy test: Consider HELLP syndrome (hemolysis, elevated liver enzymes, low platelets)
If Suspecting Obstruction
First-Line Tests
- Bladder scan: Quick assessment for retention
- Renal ultrasound: Detects hydronephrosis with sensitivity approximately 90%
- Post-void residual (catheterization): Greater than 200-300 mL significant
Second-Line Tests
- Non-contrast computed tomography: Best for stones; shows level of obstruction
- Computed tomography urogram: If malignancy or soft tissue cause suspected
- Magnetic resonance urography: Alternative if contrast contraindicated
- Cystoscopy and retrograde pyelography: If intervention planned
Fluid Challenge as a Diagnostic and Therapeutic Tool
The Fluid Challenge
A carefully monitored fluid challenge can help distinguish prerenal azotemia (responds) from established intrinsic acute kidney injury (does not respond):
- Patient selection: Suspected prerenal azotemia without signs of volume overload
- Technique: Administer 250-500 mL crystalloid (normal saline or balanced solution) over 15-30 minutes
- Monitor: Urine output, blood pressure, jugular venous pressure, lung examination
- Positive response: Urine output increases to greater than 0.5 mL/kg/hour within 2 hours
- Caution: Stop if signs of fluid overload develop (crackles, increasing jugular venous pressure, oxygen desaturation)
Important: Failure to respond does not necessarily mean intrinsic renal disease—the patient may still be volume depleted but require more aggressive resuscitation, or there may be a mixed picture.
When to Consult Nephrology
| Indication | Urgency | Reason |
|---|---|---|
| Need for renal replacement therapy | EMERGENT | Refractory hyperkalemia, severe acidosis, refractory volume overload, uremic complications |
| Suspected rapidly progressive glomerulonephritis | EMERGENT | May require urgent biopsy and immunosuppression; hours matter |
| Suspected thrombotic microangiopathy | EMERGENT | Thrombotic thrombocytopenic purpura requires urgent plasma exchange |
| Acute kidney injury with unclear etiology | URGENT | May need biopsy for diagnosis; specialized testing |
| Acute kidney injury not responding to initial management | URGENT | May need advanced diagnostics or change in management |
| KDIGO Stage 3 acute kidney injury | URGENT | High risk for complications and need for dialysis |
| Acute kidney injury in kidney transplant patient | URGENT | Complex management; may indicate rejection |
Indications for Urgent Dialysis: “AEIOU”
- A — Acidosis: Severe metabolic acidosis (pH less than 7.1) refractory to bicarbonate therapy
- E — Electrolytes: Refractory hyperkalemia (greater than 6.5 mEq/L with electrocardiogram changes) despite medical management
- I — Intoxication: Dialyzable toxins (methanol, ethylene glycol, lithium, salicylates)
- O — Overload: Volume overload with pulmonary edema refractory to diuretics
- U — Uremia: Uremic complications (encephalopathy, pericarditis, bleeding diathesis)
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent? Initial Triage
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Hyperkalemia with electrocardiogram changes (peaked T waves, widened QRS) | EMERGENT | Calcium gluconate immediately; insulin/glucose; consider emergent dialysis |
| Severe pulmonary edema with respiratory distress | EMERGENT | Oxygen, upright positioning, intravenous diuretics; prepare for possible dialysis/ultrafiltration |
| Uremic pericarditis (friction rub, chest pain) | EMERGENT | Urgent nephrology consultation for dialysis; risk of tamponade |
| Altered mental status with asterixis (uremic encephalopathy) | EMERGENT | Urgent dialysis; rule out other causes of encephalopathy |
| Complete anuria (no urine output for greater than 12 hours) | EMERGENT | Immediate bladder catheterization; urgent renal ultrasound; consider vascular occlusion |
| Suspected rapidly progressive glomerulonephritis (active sediment, rising creatinine) | EMERGENT | Urgent nephrology consultation; send serologies; may need emergent biopsy and treatment |
| Oliguria with hemodynamic instability (septic or cardiogenic shock) | URGENT | Resuscitation, vasopressors if needed, treat underlying cause; intensive care unit admission |
| New oliguria in hospitalized patient | URGENT | Assess volume status, review medications, check bladder, obtain urine studies |
| Oliguria with stable vital signs, no complications | ROUTINE | Systematic evaluation; address prerenal factors; monitor closely |
Step 2: The First 30 Minutes — Rapid Assessment
Immediate Actions When Oliguria is Identified:
- Verify oliguria is real: Check catheter for kinks or obstruction; flush if needed; confirm accurate measurement
- Assess hemodynamic status: Blood pressure, heart rate, perfusion (capillary refill, mental status)
- Rule out obstruction: Bladder scan or catheterize; if greater than 300-500 mL obtained, obstruction confirmed
- Review recent events: Hypotensive episodes, contrast exposure, new medications, procedures
- Order immediate labs: Basic metabolic panel (creatinine, potassium, bicarbonate), urinalysis
- Obtain electrocardiogram: If potassium result pending or known to be elevated
Step 3: Classify by Mechanism
Prerenal?
Clinical clues:
- History of volume loss or reduced intake
- Hypotension or orthostatic changes
- Signs of dehydration
- Heart failure or cirrhosis
Lab clues:
- Blood urea nitrogen-to-creatinine ratio greater than 20:1
- Fractional excretion of sodium less than 1%
- Urine specific gravity greater than 1.020
- Bland urine sediment
Action: Fluid challenge if appropriate; treat underlying cause
Intrinsic Renal?
Clinical clues:
- Prolonged hypoperfusion
- Nephrotoxin exposure
- Systemic disease symptoms
- Dark or bloody urine
Lab clues:
- Fractional excretion of sodium greater than 2%
- Muddy brown casts (acute tubular necrosis)
- Red blood cell casts (glomerulonephritis)
- White blood cell casts (interstitial nephritis)
Action: Identify specific cause; nephrology consultation; consider biopsy
Postrenal?
Clinical clues:
- History of prostatic disease
- Pelvic malignancy
- Kidney stones
- Palpable bladder
Lab/Imaging clues:
- High post-void residual
- Hydronephrosis on ultrasound
- Variable urine indices
Action: Relieve obstruction (catheter, nephrostomy, stent); urology consultation
Step 4: Scenario-Based Decision Making
Algorithm A: Oliguria in the Hypotensive Patient
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Hypotension + fever + tachycardia + identifiable infection source | Sepsis-associated acute kidney injury | Fluid resuscitation (30 mL/kg crystalloid); antibiotics within 1 hour; vasopressors if fluid-refractory; source control |
| Hypotension + elevated jugular venous pressure + S3 gallop + pulmonary crackles | Cardiogenic shock / Cardiorenal syndrome | Diuretics (if volume overloaded); inotropes if needed; avoid excessive fluids; cardiology consultation |
| Hypotension + obvious blood loss (hematemesis, melena, trauma) | Hemorrhagic shock with prerenal acute kidney injury | Aggressive fluid resuscitation; blood transfusion; identify and control bleeding source |
| Hypotension + flat jugular venous pressure + dry mucous membranes + history of losses | Hypovolemic shock | Rapid fluid resuscitation; identify and replace ongoing losses; monitor response |
| Hypotension + distended neck veins + muffled heart sounds | Cardiac tamponade | Urgent echocardiography; pericardiocentesis if confirmed; cardiology/cardiac surgery consultation |
Algorithm B: Oliguria in the Normotensive Patient
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Palpable bladder + elderly male + weak urinary stream | Bladder outlet obstruction (benign prostatic hyperplasia) | Insert urinary catheter; monitor post-obstructive diuresis; urology consultation |
| Contrast exposure 48-72 hours ago + rising creatinine | Contrast-induced nephropathy | Supportive care; maintain hydration; avoid further nephrotoxins; usually self-limited |
| Recent aminoglycoside or vancomycin therapy + gradual creatinine rise | Nephrotoxic acute tubular necrosis | Stop or adjust nephrotoxin; supportive care; therapeutic drug monitoring |
| New medication 1-3 weeks ago + fever + rash (may be absent) | Acute interstitial nephritis | Discontinue offending drug; consider steroids if severe or not improving |
| Muscle pain + dark urine + elevated creatine kinase | Rhabdomyolysis | Aggressive intravenous fluids (goal urine output 200-300 mL/hour); monitor potassium and calcium |
| Hematuria + hypertension + red blood cell casts + systemic symptoms | Acute glomerulonephritis | Urgent nephrology consultation; send serologies; likely need biopsy |
| Known cirrhosis + ascites + no other clear cause | Hepatorenal syndrome | Rule out infection (diagnostic paracentesis); albumin challenge; vasoconstrictors (terlipressin, midodrine/octreotide) |
Algorithm C: Oliguria in the Postoperative Patient
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Immediate postoperative oliguria + low urine output from start | Intraoperative hypovolemia or hypotension | Assess volume status; fluid challenge if appropriate; review operative record for hypotensive episodes |
| Post-pelvic surgery + complete anuria | Iatrogenic ureteral injury (bilateral ligation) | Urgent renal ultrasound; urology consultation; may need surgical exploration |
| Post-cardiac surgery + hemodynamic instability | Low cardiac output state / Cardiopulmonary bypass-related | Optimize cardiac output; inotropes if needed; may be multifactorial |
| Post-abdominal surgery + tense distended abdomen | Abdominal compartment syndrome | Measure bladder pressure; if greater than 20 mmHg with organ dysfunction, consider decompressive laparotomy |
| Post-vascular surgery (aortic) + flank pain + hematuria | Renal artery thrombosis or atheroembolism | Urgent imaging (computed tomography angiography); vascular surgery consultation |
“What Do I Do If…” Practical Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on angiotensin-converting enzyme inhibitor with new oliguria and creatinine rise | Hold angiotensin-converting enzyme inhibitor immediately | Assess volume status; check potassium; expect improvement in 3-7 days; investigate for renal artery stenosis if bilateral kidneys |
| Potassium is 6.8 mEq/L with peaked T waves | Calcium gluconate 1-2 grams intravenously over 2-3 minutes (cardiac membrane stabilization) | Insulin 10 units + glucose 50 mL of 50% dextrose; sodium bicarbonate if acidotic; kayexalate; prepare for dialysis |
| Patient develops flash pulmonary edema with oliguria | Sit patient upright; high-flow oxygen; intravenous furosemide 40-80 mg (or double home dose) | If no response to diuretics, urgent nephrology consultation for ultrafiltration/dialysis |
| Foley catheter is draining minimal urine | Flush catheter with 30-50 mL saline to confirm patency | If no return or minimal return, catheter may be blocked or patient is truly oliguric; replace catheter if in doubt |
| Ultrasound shows bilateral hydronephrosis | Insert urinary catheter if not already present | If hydronephrosis persists after catheter drainage, obstruction is at ureteral level; urology consultation for stents or nephrostomy |
| Patient has oliguria but is clearly volume overloaded | Do NOT give fluids; consider diuretic challenge | Furosemide 40-80 mg intravenous bolus; if no response, may need higher doses or continuous infusion; consider dialysis for ultrafiltration |
| Fractional excretion of sodium is 0.5% but patient received diuretics | Calculate fractional excretion of urea instead | Fractional excretion of urea less than 35% suggests prerenal; greater than 50% suggests intrinsic; clinical context remains important |
| Oliguria persists despite adequate fluid resuscitation | Re-evaluate diagnosis; consider that prerenal has progressed to acute tubular necrosis | Stop further aggressive fluids if patient is euvolemic; focus on supportive care; prepare for possible need for renal replacement therapy |
Managing Post-Obstructive Diuresis
After relief of urinary obstruction, significant diuresis may occur. This can be physiological (clearing accumulated fluid and solutes) or pathological (impaired concentrating ability):
- Monitor urine output hourly for the first 24-48 hours after relief of obstruction
- Replace approximately 50-75% of urine output with half-normal saline if output exceeds 200 mL/hour
- Check electrolytes every 6-12 hours initially; watch for hyponatremia, hypokalemia, hypomagnesemia
- Avoid over-replacement which perpetuates the diuresis
- Diuresis typically resolves within 24-72 hours; prolonged diuresis (greater than 48-72 hours) may indicate tubular damage
Troubleshooting Refractory Oliguria
When Oliguria Does Not Improve: Ask These Questions
- Is the diagnosis correct? Re-examine for obstruction; consider alternative diagnoses (glomerulonephritis, vascular occlusion)
- Is there ongoing injury? Persistent hypoperfusion, continued nephrotoxin exposure, uncontrolled sepsis
- Has prerenal progressed to intrinsic? Prolonged hypoperfusion leads to acute tubular necrosis; this is no longer rapidly reversible
- Are there multiple overlapping causes? Common in critically ill patients (sepsis + nephrotoxins + hypoperfusion)
- Is the patient developing complications? Check for hyperkalemia, acidosis, volume overload requiring dialysis
- Should nephrology be involved? If not already consulted, involve nephrology for persistent or worsening acute kidney injury
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Always rule out obstruction first: Postrenal causes are the most rapidly reversible if caught early, but cause irreversible damage if missed. A simple bladder scan or catheterization takes minutes and can be diagnostic and therapeutic.
Prerenal and intrinsic exist on a continuum: Prolonged prerenal azotemia (greater than 24-48 hours) leads to ischemic acute tubular necrosis. Early recognition and treatment of prerenal states prevents progression to established acute kidney injury.
The urine sediment is your best friend: A careful examination of the urine sediment can distinguish prerenal (bland or hyaline casts) from acute tubular necrosis (muddy brown granular casts) from glomerulonephritis (red blood cell casts) from interstitial nephritis (white blood cell casts).
Complete anuria is a red flag: True anuria (essentially no urine output) is unusual in most causes of acute kidney injury. It strongly suggests complete obstruction, bilateral renal artery occlusion, or severe acute cortical necrosis. Investigate urgently.
Fractional excretion of urea is more reliable with diuretics: If the patient has received diuretics, fractional excretion of sodium is unreliable. Use fractional excretion of urea instead (less than 35% suggests prerenal).
Think about medications in every case: A thorough medication review is essential. Nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and aminoglycosides are common culprits. Over-the-counter medications and supplements count too.
Volume overload does not equal adequate perfusion: Patients can be total-body volume overloaded (edema, ascites) yet have decreased effective circulating volume (heart failure, cirrhosis). These patients need diuretics, not fluids.
Creatinine is a lagging indicator: Serum creatinine does not begin to rise until glomerular filtration rate has fallen by approximately 50%. By the time creatinine is elevated, significant injury has already occurred. Urine output is an earlier indicator.
Critical Pitfalls to Avoid
Giving fluids to every patient with oliguria: Not all oliguria is due to volume depletion. Giving fluids to a patient with heart failure or volume overload can precipitate pulmonary edema. Always assess volume status before giving fluids.
Forgetting to check the catheter: Before attributing low urine output to renal failure, ensure the Foley catheter is patent. Flush it, check for kinks, and consider replacing it if there is any doubt.
Missing obstruction because ultrasound is “negative”: Hydronephrosis may be absent early in obstruction, in severe dehydration, or if the collecting system is encased by tumor or fibrosis. If clinical suspicion is high, pursue further imaging.
Delaying nephrology consultation in rapidly progressive disease: Rapidly progressive glomerulonephritis can destroy kidney function within days to weeks. Early biopsy and treatment can preserve function. When in doubt, consult early.
Relying solely on fractional excretion of sodium: Fractional excretion of sodium can be low (less than 1%) in contrast nephropathy, rhabdomyolysis, early sepsis, and glomerulonephritis despite intrinsic injury. Use clinical context and urine sediment examination.
Continuing nephrotoxins while “monitoring” creatinine: If a patient develops acute kidney injury while on aminoglycosides, vancomycin, or other nephrotoxins, stop or adjust immediately. Do not wait for the creatinine to rise further.
Ignoring hyperkalemia until electrocardiogram changes appear: Electrocardiogram changes are an unreliable marker of hyperkalemia severity. Treat significant hyperkalemia (greater than 6.0 mEq/L) proactively; do not wait for peaked T waves or widened QRS.
Using “renal dose” dopamine: Low-dose dopamine does not prevent or treat acute kidney injury. Multiple randomized trials have shown no benefit. This practice should be abandoned.
Key Takeaways
- Oliguria is defined as urine output less than 0.5 mL/kg/hour for at least 6 hours or less than 400-500 mL per 24 hours in adults.
- The first question to answer is: prerenal, intrinsic renal, or postrenal? This determines management and prognosis.
- Always rule out obstruction early—it is the most readily reversible cause if identified promptly.
- Prerenal azotemia is characterized by low fractional excretion of sodium (less than 1%), concentrated urine, and bland sediment; it responds to restoration of perfusion.
- Intrinsic acute kidney injury (especially acute tubular necrosis) shows fractional excretion of sodium greater than 2%, isosthenuria, and muddy brown granular casts; it requires supportive care and time to recover.
- Medication review is essential in every case—nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aminoglycosides, and contrast are common culprits.
- Volume status assessment is critical but challenging—integrate history, examination, laboratory data, and consider dynamic tests or point-of-care ultrasound when uncertain.
- Red blood cell casts indicate glomerulonephritis and warrant urgent nephrology consultation and serological workup.
- The “AEIOU” indications for urgent dialysis are: Acidosis (refractory), Electrolytes (hyperkalemia), Intoxication, Overload (volume), and Uremia (encephalopathy, pericarditis).
- Early recognition and treatment of prerenal states prevents progression to established acute tubular necrosis—the window for intervention is often measured in hours.
Quick Reference Algorithm
Systematic Approach to Oliguria:
- Verify and quantify: Confirm oliguria is real (check catheter patency, accurate measurement)
- Assess stability: Check vital signs, potassium, volume status; treat emergencies first (hyperkalemia, pulmonary edema)
- Rule out obstruction: Bladder scan or catheterize; renal ultrasound for hydronephrosis
- Classify mechanism: Use history, examination, blood urea nitrogen-to-creatinine ratio, fractional excretion of sodium, and urine sediment to distinguish prerenal versus intrinsic versus postrenal
- Review medications: Identify and stop/adjust nephrotoxins; hold angiotensin-converting enzyme inhibitors/angiotensin receptor blockers if appropriate
- Treat underlying cause: Fluids for hypovolemia, diuretics for overload, antibiotics for sepsis, relieve obstruction
- Monitor and reassess: Trend creatinine, urine output, electrolytes; escalate if not improving
- Consult nephrology: For severe or worsening acute kidney injury, unclear diagnosis, need for dialysis, or suspected glomerulonephritis